Literature DB >> 6086771

Evidence for an epidemic trimethoprim-resistance plasmid in fecal isolates of Escherichia coli from citizens of the United States studying in Mexico.

R P Rudy, B E Murray.   

Abstract

A previous study revealed the emergence of high-level resistance to trimethoprim-sulfamethoxazole in strains of Escherichia coli isolated from 95% of students from the United States who were taking either trimethoprim alone or trimethoprim-sulfamethoxazole for prophylaxis of travelers' diarrhea while in Guadalajara, Mexico. Many of these strains were subsequently demonstrated to cotransfer resistance to trimethoprim along with that to streptomycin and ampicillin. The present study demonstrated that at least 12 (60%) of 20 transferable (tra+) trimethoprim-resistance plasmids studied possessed both an identical Hind III restriction pattern and type I dihydrofolate reductase genes. Donor strains were shown to be distinct; this finding suggested that a common tra+ trimethoprim-resistance plasmid was widely disseminated among E. coli strains in Guadalajara. These results may explain in part the surprising degree of resistance encountered in trimethoprim-consuming persons in that region.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6086771     DOI: 10.1093/infdis/150.1.25

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  3 in total

1.  In vitro studies of plasmid-mediated penicillinase from Streptococcus faecalis suggest a staphylococcal origin.

Authors:  B E Murray; B Mederski-Samoraj; S K Foster; J L Brunton; P Harford
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

Review 2.  Studies of antimicrobial resistance genes using DNA probes.

Authors:  F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

3.  Molecular epidemiology of Shigella infections: plasmid profiles, serotype correlation, and restriction endonuclease analysis.

Authors:  C M Litwin; A L Storm; S Chipowsky; K J Ryan
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.